De Novo device
cobas EBV, cobas EBV/BKV Control Kit, cobas Buffer Negative Control Kit
Roche Molecular Systems, Inc. · Nucleic Acid Amplification Test For The Quantitation Of Epstein-Barr Virus (Ebv) Dna (QLX, Class II) · First FDA decision Jul 30, 2020, newest Jul 30, 2020Kidney failure and dialysis
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
Breakthrough-designated
Device trials
0
Naming "cobas EBV cobas"
MAUDE reports
0
Brand "cobas EBV cobas", since 2015
PubMed studies
0
Mentioning "cobas EBV cobas"
AI summary across all sources
Written by Claude (Anthropic's AI) from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- cobas EBV, cobas EBV/BKV Control Kit, cobas Buffer Negative Control KitNew device typeBreakthroughDe Novo
DEN200015 · Decided Jul 30, 2020 · 150 days after receipt
Device type: Nucleic Acid Amplification Test For The Quantitation Of Epstein-Barr Virus (Ebv) Dna (QLX) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Gastrointestinal Pathogen (GIP) Panels Utilizing Multiplex Nucleic Acid Amplification Techniques (NAATs)Local determinationIn effectL38227First Coast Service Options, Inc.Updated Oct 20, 2023
- Gastrointestinal Pathogen (GIP) Panels Utilizing Multiplex Nucleic Acid Amplification Techniques (NAATs)Local determinationIn effectL38229Novitas Solutions, Inc.Updated Oct 20, 2023
Clinical trials
Device studies on ClinicalTrials.gov that name "cobas EBV cobas", any status and sponsor, newest update first.
No registered device study names "cobas EBV cobas".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "cobas EBV cobas", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QLX
8 reports: 8 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "cobas EBV cobas"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code QLX.
- Alinity m EBV (09N43-095)Abbott Molecular, Inc. · 510(k) 2025
- cobas BKVRoche Molecular Systems, Inc. · 510(k) 2021
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.